SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmacyclics (PCYC)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: squetch who wrote (294)5/11/1998 2:00:00 PM
From: Henry Niman  Read Replies (2) of 717
 
I thought it was odd. The report was by CNBC on some market segment. The reporter indicated that PCYC was to present on Tuesday at ASCO and analysts experceted positive results. The technology was described in general terms (sensitizing tumor to radiation) and a second compound was mentioned.

The report seemed strange because no one from the company was interviewed and the report seemed very positive about news that had not come out yet.

If you were watching the ticker, you know the rest.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News